News

Filter
70 found

New publication highlights efficacy of MMV048 against resistant strains of malaria

27 Apr 2017

New antimalarial compound treats and protects in a single dose

29 Mar 2017

MMV partner Prof. David Fidock wins the 2016 Advance Global Australian of the Year Award in Life Sciences

21 Oct 2016

First open source malaria publication describes new way to do drug discovery

14 Sep 2016

PLOS Pathogens publishes the Malaria Box findings

28 Jul 2016

MMV awards seven endemic-region scientists Challenge Grants to ‘exploit the Pathogen Box’

25 Jul 2016

Endemic-Region Challenge Grants of USD 50,000 each available to exploit the Pathogen Box

31 Mar 2016

MMV launches the Pathogen Box

14 Dec 2015
European regulators grant Pyramax® a revised label

European regulators grant Pyramax® a revised label

20 Nov 2015

WHO awards over $1 million to MMV’s ‘Exploiting the Pathogen Box’ project

19 Aug 2015

Pre-clinical assessment of exciting new malaria drug candidate published

16 Jul 2015

OZ439 recognized as a high-impact innovation to transform global health

16 Jul 2015

MMV wins Tim Berners-Lee’s Open Data Innovation Award

10 Jul 2015

MMV awards challenge grants to seven Malaria Box recipients

06 Mar 2015

First Chair of MMV’s ESAC receives knighthood

12 Jan 2015

Three new roads leading to a common pathway

09 Dec 2014

MMV partner Prof. Luiz Carlos Dias receives Santander University Award

13 Nov 2014

MMV organizes international malaria conference in Berlin

01 Jul 2014

MMV and Merck Serono join forces in antimalarial drug discovery

24 Feb 2014

MMV and partners call for compounds to fill the Pathogen Box

18 Feb 2014

Tafenoquine successfully completes Phase IIb clinical trials

19 Dec 2013

State-of-the-art laboratory to study new antimalarials opens in Jakarta

10 Dec 2013

New antimalarial drug target identified

29 Nov 2013

Partners commit to bolstering open source research

27 Nov 2013

MMV signs MoU with Takeda and GHIT (Japan)

11 Nov 2013

MMV partner receives PLOS Accelerating Science Award

23 Oct 2013

First-ever drug compound developed on African soil, an antimalarial, to move to human trials

08 Oct 2013

MMV’s ‘Challenge Model’ creates a buzz in Australia

16 Sep 2013

Potential new class of antimalarials now open source

10 Sep 2013

African research is rising

12 Jul 2013

Quinolones: breathing new life into an old class of compounds to tackle malaria

20 Mar 2013

Salt pumps: A chink in the malaria parasite’s armour

21 Feb 2013

Focusing on malaria drug discovery

13 Dec 2012

Momentum builds for neglected diseases drug discovery

21 Sep 2012

Improving safety for antimalarial drugs

31 Aug 2012

New medicine for relapsing malaria being evaluated in four countries

27 Aug 2012

MMV and the European Bioinformatics Institute establish one-stop shop for malaria drug data

13 Jul 2012

OZ439 clears the first clinical development hurdle

11 Jul 2012

Sharing the fruits of science to accelerate drug discovery

22 Mar 2012

Rewarding innovative ideas

22 Mar 2012

Double commendation for MMV ESAC member

15 Mar 2012

Do you have an idea that could revolutionize malaria drug discovery?

12 Jan 2012

Former MMV ESAC member awarded Queen’s New Year Honour

03 Jan 2012

Eurartesim® receives stringent regulatory approval from the EMA

10 Nov 2011

MMV ESAC member receives accolade for malaria research

22 Aug 2011

Pyramax® edges closer to patients

19 Aug 2011

Ground-breaking trial underway to protect pregnant women from malaria

28 Jan 2011

Conclusive win of artesunate over quinine

08 Nov 2010

MMV-supported artesunate for injection receives WHO prequalification

08 Nov 2010

Optimizing development of combination therapies: the regulatory perspective

08 Oct 2010

Selecting the right partner drug: experts debate the issues

13 Sep 2010

Over 5 million compounds screened

03 May 2010

MMV in Trends in Parasitology

01 Feb 2010

Join the CRIMALDDI online discussion

20 Jan 2010

MMV in Nature Reviews Drug Discovery

06 Nov 2009

New EU-funded project to coordinate antimalarial drug research

24 Aug 2009

MMV to use HEOS database developed by SCYNEXIS

13 May 2009

The power of partnership

16 Apr 2009

MMV to collaborate with GSK on development of Tafenoquine for P.Vivax malaria

15 Dec 2008

New technologies gearing up to meet rising demand for antimalarials

19 Nov 2008

Pages